A school-based human papillomavirus (HPV) immunization program in British Columbia, Canada, is dramatically reducing rates of cervical pre-cancer in B.C. women, according to a new study.
Read moreA single dose of a highly diluted VSV-Ebola virus (EBOV) vaccine — approximately one-millionth of what is in the vaccine being used to help control the ongoing Ebola outbreak in the Democratic Republic of the Congo — remains fully protective against disease in experimentally infected monkeys, according to scientists. The investigators completed the dosage study using cynomolgus macaques and an updated vaccine component to match the EBOV Makona strain that circulated in West Africa from 2014-16.
Read moreThere is no effective vaccine currently available to prevent Lyme disease in humans. Experts from academia, government, and industry recently convened to tackle this public health challenge. Now, a new article reiterates the need to stop the infection, and defines a strategy for developing effective vaccines.
Read morePredicting and controlling disease outbreaks would be easier and more reliable with the wider application of mathematical modelling, according to a new study.
Read moreRotavirus infection may play a role in the development of type 1 diabetes, according to a new article.
Read moreScientists show, on the molecular level, how an experimental vaccine offers long-term protection against the disease.
Read moreA vaccine for the common and sometimes deadly RSV (respiratory syncytial virus) has been elusive, but scientists say a new discovery puts them much closer to success.
Read moreMIT chemical engineers have developed a new type of lipid nanoparticle that can be used to deliver RNA vaccines. The particles also trigger the release of powerful immune signaling proteins that boost the vaccines' effectiveness.
Read moreA new type of vaccine that can be stored at warmer temperatures, removing the need for refrigeration, has been developed for mosquito-borne virus Chikungunya in a major advance in vaccine technology. The findings reveal exceptionally promising results for the Chikungunya vaccine candidate, which has been engineered using a synthetic protein scaffold that could revolutionise the way vaccines are designed, produced and stored.
Read moreThe World Health Organization has made it a goal to eliminate human rabies deaths due to dog bites by the year 2030. An increase in dog rabies vaccination rates decreases dog rabies cases, human exposure, and human deaths, researchers now report.
Read more